13D/13G Filings - SUVRETTA CAPITAL MANAGEMENT LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, ...5, 6, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-02
5:40 pm
Purchase
2025-03-3113GImmatics N.V.
IMTX
SUVRETTA CAPITAL MANAGEMENT LLC9,135,029
7.500%
1,253,421increase
(+15.90%)
Filing
History
2025-05-02
5:37 pm
Purchase
2025-03-3113G89bio, Inc.
ETNB
SUVRETTA CAPITAL MANAGEMENT LLC14,611,409
9.900%
4,408,713increase
(+43.21%)
Filing
History
2025-05-02
5:33 pm
Purchase
2025-03-3113GFulcrum Therapeutics, Inc.
FULC
SUVRETTA CAPITAL MANAGEMENT LLC5,067,394
9.400%
1,662,782increase
(+48.84%)
Filing
History
2025-05-02
5:16 pm
Purchase
2025-03-3113GKura Oncology, Inc.
KURA
SUVRETTA CAPITAL MANAGEMENT LLC7,561,000
9.400%
2,362,811increase
(+45.45%)
Filing
History
2025-05-02
5:14 pm
Purchase
2021-06-1513GMolecular Partners AG
MOLN
SUVRETTA CAPITAL MANAGEMENT LLC4,284,806
10.600%
4,284,806increase
(New Position)
Filing
History
2025-04-16
5:30 pm
Purchase
2025-04-0913GMonte Rosa Therapeutics, Inc.
GLUE
SUVRETTA CAPITAL MANAGEMENT LLC3,360,000
5.500%
3,360,000increase
(New Position)
Filing
History
2025-04-11
5:57 pm
Purchase
2025-04-0413GAura Biosciences, Inc.
AURA
SUVRETTA CAPITAL MANAGEMENT LLC3,057,319
6.100%
3,057,319increase
(New Position)
Filing
History
2025-04-11
4:46 pm
Purchase
2025-04-0713GDBV Technologies S.A.
DBVT
SUVRETTA CAPITAL MANAGEMENT LLC15,176,015
9.900%
15,176,015increase
(New Position)
Filing
History
2025-03-28
4:50 pm
Purchase
2025-03-2613DBenitec Biopharma Inc.
BNTC
SUVRETTA CAPITAL MANAGEMENT LLC15,623,659
49.900%
1,293,722increase
(+9.03%)
Filing
History
2025-03-11
7:22 pm
Purchase
2025-03-0413GWhitehawk Therapeutics Inc
WHWK
SUVRETTA CAPITAL MANAGEMENT LLC4,727,510
9.990%
4,727,510increase
(New Position)
Filing
History
2025-02-13
8:15 pm
Sale
2024-12-3113GKura Oncology, Inc.
KURA
SUVRETTA CAPITAL MANAGEMENT LLC5,198,189
6.700%
-2,274,154decrease
(-30.43%)
Filing
History
2025-02-13
8:09 pm
Sale
2024-12-3113GErasca, Inc.
ERAS
SUVRETTA CAPITAL MANAGEMENT LLC12,315,004
4.400%
-1,453,035decrease
(-10.55%)
Filing
History
2025-02-13
8:00 pm
Purchase
2024-12-3113G89bio, Inc.
ETNB
SUVRETTA CAPITAL MANAGEMENT LLC10,202,696
8.500%
2,211,052increase
(+27.67%)
Filing
History
2025-02-11
8:51 pm
Purchase
2025-02-0413GImmatics N.V.
IMTX
SUVRETTA CAPITAL MANAGEMENT LLC7,881,608
6.500%
7,881,608increase
(New Position)
Filing
History
2025-02-11
8:45 pm
Purchase
2025-02-0713GMarinus Pharmaceuticals, Inc.
MRNS
SUVRETTA CAPITAL MANAGEMENT LLC3,022,612
5.500%
917,348increase
(+43.57%)
Filing
History
2025-02-11
8:20 pm
Sale
2024-12-3113GMarinus Pharmaceuticals, Inc.
MRNS
SUVRETTA CAPITAL MANAGEMENT LLC2,105,264
3.800%
-3,358,377decrease
(-61.47%)
Filing
History
2025-02-07
5:36 pm
Purchase
2025-02-0513GPepGen Inc.
PEPG
SUVRETTA CAPITAL MANAGEMENT LLC1,660,932
5.100%
486,611increase
(+41.44%)
Filing
History
2025-02-07
5:16 pm
Sale
2024-12-3113GPepGen Inc.
PEPG
SUVRETTA CAPITAL MANAGEMENT LLC1,174,321
3.600%
-486,611decrease
(-29.30%)
Filing
History
2025-01-06
4:50 pm
Purchase
2024-12-2713GFulcrum Therapeutics, Inc.
FULC
SUVRETTA CAPITAL MANAGEMENT LLC3,404,612
6.300%
2,221,821increase
(+187.85%)
Filing
History
2024-12-20
4:56 pm
Purchase
2024-12-1313GPalvella Therapeutics, Inc.
PVLA
SUVRETTA CAPITAL MANAGEMENT LLC714,463
8.600%
714,463increase
(New Position)
Filing
History
Goto 0, 1, 2, ...5, 6, Next